Prof Srikumar Leads Breakthrough In Rare Cancer Research

Groundbreaking research from SEGi University has brought new insights to light on Gorlin-Goltz Syndrome (GGS), a rare hereditary cancer disorder, through a compelling new case report and literature review. The study, published in the Journal of Pharmaceutical Research, offers clinicians and researchers a deeper understanding of diagnostic markers and the complexity of this syndrome, which includes over 100 recognised anomalies.

The research was led by Prof Srikumar Chakravarthi, Deputy Vice Chancellor of SEGi University and a renowned figure in medical pathology. His role as first author highlights SEGi’s academic leadership and strong positioning in rare disease research. The collaborative study also involved researchers from SRM University, India, and Universitas Negeri Surabaya, Indonesia — further cementing SEGi’s global network of scientific partnerships.

For full article – https://university.segi.edu.my/prof-srikumar-leads-breakthrough-in-rare-cancer-research/

This event is organised in support of the following United Nations Sustainable Development Goals (SDG):
SDG 3 – Good Health and Well-being
SDG 4 – Quality Education
SDG 17 – Partnerships for the Goals